Tirana

Tirana is rapidly emerging as a central hub for the Western Balkans' life sciences ecosystem, distinguished by its strategic integration of pharmaceutical manufacturing and healthcare innovation.

The city is best known for being a regional stronghold for generic drug production, with major international players like Krka and Nobel Pharmaceuticals maintaining a significant presence to serve the broader Mediterranean market.

Beyond traditional pharma, Tirana is accelerating its biotechnology footprint through the Western Balkans University Research Center for Medical Sciences, Technology and Innovation, which focuses on genomics, proteomics and molecular diagnostics.

The city’s medtech sector is also seeing a surge, supported by global compliance leaders like SGS Albania, ensuring that locally developed medical devices meet rigorous EU MDR and ISO 13485 standards.

Academic excellence is anchored by the University of Tirana, which spearheads clinical research and international collaborations in antimicrobial resistance and bioengineering.

Public-private partnerships are fostering a robust digital health landscape, where AI-enhanced medical decision-making and telemedicine startups are gaining traction.

The capital’s ecosystem is further bolstered by its status as a gateway for clinical trials in Southeast Europe, offering a diverse patient pool and a streamlining regulatory environment.

With the support of the European Institute of Innovation and Technology (EIT), Tirana is transitioning from a regional distributor to a high-value R&D destination.

This evolution is positioning Albania's capital as a competitive destination for biotech investment and life science talent looking to capitalize on an untapped, high-growth market.